Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 7—July 2012

Dispatch

Seroconversion to Seasonal Influenza Viruses after A(H1N1)pdm09 Virus Infection, Quebec, Canada

Mariana Baz, Jesse Papenburg, Marie-Eve Hamelin, Manale Ouakki, Danuta M. Skowronski, Gaston De Serres, and Guy BoivinComments to Author 
Author affiliations: Author affiliations: Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec, Canada (M. Baz, J. Papenburg, M.-E. Hamelin, G. Boivin); Laval University, Quebec City (M. Baz, J. Papenburg, M.-E. Hamelin, G. Boivin); Institut National de Santé Publique du Quebec, Quebec (M. Ouakki, G. De Serres); British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada (D.M. Skowronski)

Main Article

Table

Clinical features and microneutralization antibody titers against influenza A(H1N1)pdm09 and seasonal influenza A viruses of persons who seroconverted to >2 influenza viruses, Quebec City, Quebec, Canada, 2009*

Participant no./age, y RT-PCR for A(H1N1) pdm09 Titers, acute phase/convalescent phase (-fold increase)
Symptoms
A/Quebec/147023/ 2009; A(H1N1)pdm09 A/Brisbane/59/ 2007 (H1N1) A/New Caledonia/ 99 (H1N1) A/Panama/2007/99 (H3N2)
ARI ILI
39A/7 + + + <10/160 (16) <10/320 (32) <10/160 (16) 320/160 (0)
39C/11 + + + <10/40 (4) 10/160 (16) <10/40 (4) 2,560/2,560 (0)
49A/28 + + + <10/160 (16) 40/160 (4) <10/20 (2) 320/320 (0)
49B/23 + + + <10/640 (64) <10/160 (16) 40/160 (4) 40/40 (0)
55F/7 + + + <10/40 (4) 10/40 (4) 20/80 (4) 10/10 (0)
16C/7 + + + <10/80 (8) 160/320 (2) 40/160 (4) 80/80 (0)
56A/12 + + + <10/40 (4) 80/320 (4) 40/80 (2) 2,560/2,560 (0)
65B/40 + + + <10/320 (32) <10/20 (2) 10/40 (4) 320/320 (0)
03E/17 + + + <10/80 (8) 40/80 (2) 160/160 (0) 640/5120 (8)
10B/14 + + + <10/80 (8) 20/20 (0) 80/320 (4) 640/640 (0)
11C/61† + + + <10/1,280 (128) 40/160 (4) 160/160 (0) 320/1,280 (4)
44B/9 + + + <10/<80 (8) 1,280/640 (0) 1,280/1,280 (0) 160/640 (4)
44C/44 + <10/20 (2) 10/80 (8) 80/80 (0) 160/640 (4)
58A/13 + + + <10/80 (8) <10/20 (2) 10/20 (2) 1,280/5,120 (4)
58B/43 + + <10/160 (16) <10/10 (0) <10/<10 (0) 20/160 (8)

*RT-PCR, reverse transcription PCR; ARI, acute respiratory illness (i.e., presence of ≥2 of the following signs/symptoms: fever [≥37.8°C] or feverishness, cough, sore throat, or rhinorrhea); ILI, influenza-like illness (i.e., fever and cough and/or sore throat); +, positive; –, negative.
†Received seasonal vaccine in 2008–09.

Main Article

TOP